The National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $387,422 firm fixed price purchase order to the Regents of the University of Colorado Office of Contracts and Grants Division, doing business as the University of Colorado in Boulder. The contract calls for the prime contractor to perform state-of-the-art measurements in studies of diabetic kidney disease in type 1 and type 2 diabetes. Specifically, the contractor will provide ultrasound guided kidney biopsies, kidney and brain MRIs, PET scans using C-11 acetate, clearance studies, endovascular biopsies, pulse wave analysis, and biomarker measurements from blood and urine samples. The period of performance is from August 2, 2022 through August 1, 2023. There is no designated set-aside. The solicitation sought these technical services to support research into diabetic kidney disease for 50 participants each for MRIs and clearance studies, 30 for PET scans, 20 for kidney biopsies, 50 for endovascular biopsies, and biomarker measurements and induced pluripotent stem cell reprogramming for 100 and 8 participants respectively.
Generated 12/29/23, 3:42 PM